The world is witnessing a new kind of power play, one waged not with armies, but with supply chains. China has demonstrated a willingness to leverage its dominance in critical materials, a reality recently underscored during a high-stakes diplomatic visit to Asia. This isn’t simply about rare earth minerals; it’s a glimpse into a future where control over foundational technologies dictates global influence.
Looking ahead, three technological arenas are paramount to America’s national security: artificial intelligence, quantum computing, and biotechnology. Just as China currently holds sway over U.S. manufacturing through its control of rare earths, a similar vulnerability is emerging in these cutting-edge fields. The potential for significant and escalating Chinese leverage is no longer a distant threat – it’s a present danger.
The extent of American dependence is already becoming alarmingly clear. The advancement of artificial intelligence within the U.S. relies heavily on access to specialized chemicals, printed circuit boards, and networking equipment sourced from China. Similarly, the burgeoning field of quantum computing is critically dependent on Chinese-supplied cooling equipment, precision lasers, and essential minerals.
Perhaps most concerning is the pharmaceutical sector. A recent study revealed that China is the sole supplier of at least one crucial ingredient for over a third of the nearly 2,000 medicines approved for use in the United States. This includes amoxicillin, a widely prescribed antibiotic relied upon by millions. The implications for public health are profound.
However, the United States is not without resources. American companies consistently lead global investment in research and development, and U.S. capital markets possess unparalleled depth and liquidity, capable of funding ambitious, transformative projects. A highly skilled workforce, encompassing both technical specialists and manufacturing experts, stands ready to rebuild and benefit from resilient supply chains.
Unlocking this potential requires strategic incentives. A focused effort to incentivize domestic production of critical inputs – chemicals, hardware components, materials for quantum computing, and pharmaceutical ingredients – is essential. Building on previous successes in the rare earth sector, the government must actively foster a robust domestic manufacturing base.
The Department of Defense can play a pivotal role by leveraging its procurement power. Establishing clear milestones and fostering competition will drive the development of a powerful, reliable quantum computer capable of surpassing the capabilities of today’s supercomputers. This isn’t just about technological advancement; it’s about securing a decisive strategic advantage.
Investing in biomanufacturing hubs across the nation would empower smaller firms to innovate and scale. Co-funding shared manufacturing infrastructure and streamlining regulations will accelerate the development and deployment of groundbreaking biotechnologies. This distributed approach will enhance resilience and foster a more dynamic ecosystem.
This isn’t a solitary race. The European Union, Japan, and South Korea are also investing heavily in strengthening their own manufacturing capabilities and critical supply chains. The U.S. should actively collaborate with these trusted allies, particularly when stockpiling essential materials like drug ingredients and critical minerals, as demonstrated by the recent agreement with Australia.
The U.S. government possesses the tools to navigate this new era of economic competition. However, existing agencies and departments often operate in silos, hindering a comprehensive understanding of vulnerabilities and emerging risks. Establishing an Economic Security Center would streamline coordination, enhance technical expertise, and forge stronger partnerships with the private sector.
There is a growing bipartisan consensus on the need to fortify critical supply chains, and a solid foundation has already been laid. Sustaining this momentum is paramount to ensuring the American economy can not only compete, but thrive, in this rapidly evolving technological landscape. The future demands decisive action, and the stakes are exceptionally high.
